CLINICAL TRIALS PROFILE FOR VISTIDE
✉ Email this page to a colleague
All Clinical Trials for VISTIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000135 ↗ | Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) | Completed | Johns Hopkins Bloomberg School of Public Health | Phase 2/Phase 3 | 1995-09-01 | To evaluate the efficacy and safety of a human anti-CMV monoclonal antibody, MSL-109, as adjunct therapy for controlling CMV retinitis. |
NCT00000142 ↗ | Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) | Completed | Baylor College of Medicine | Phase 2/Phase 3 | 1994-04-01 | To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis. |
NCT00000142 ↗ | Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) | Completed | Icahn School of Medicine at Mount Sinai | Phase 2/Phase 3 | 1994-04-01 | To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis. |
NCT00000142 ↗ | Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) | Completed | Johns Hopkins University | Phase 2/Phase 3 | 1994-04-01 | To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VISTIDE
Condition Name
Clinical Trial Locations for VISTIDE
Trials by Country
Clinical Trial Progress for VISTIDE
Clinical Trial Phase
Clinical Trial Sponsors for VISTIDE
Sponsor Name